Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
10 2021
Historique:
received: 02 12 2020
revised: 05 03 2021
accepted: 05 03 2021
pubmed: 10 4 2021
medline: 9 11 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

To study the feasibility of in vitro maturation of ovarian tissue oocytes for fertility preservation in transgender men on testosterone treatment. Cross-sectional study SETTING: University hospital PATIENT(S): Eighty-three transgender men enrolled from November 2015 to January 2019 INTERVENTION(S): In vitro maturation of cumulus-oocyte complexes (COCs) harvested at the time of gender confirmation surgery, and fertilization through intracytoplasmic sperm injection. In vitro maturation, fertilization, and blastulation rates; comparison of morphokinetics with vitrified-warmed oocytes; and analysis of the genetic profiles of embryos. association between serum hormone levels; COCs' morphologic characteristics, and vitrification rate. All participants were on testosterone treatment for a median of 83 (64[Quartile 1]; 113.2[Quartile 2]) weeks. A total of 1,903 COCs (mean per participant, 23 ± 15.8) were collected. The in vitro maturation rate was 23.8%, vitrification rate was 21.5%, and survival rate after warming was 72.6% (n = 151). Intracytoplasmic sperm injection was performed in 139 oocytes. The rate of normal fertilized oocytes was 34.5%, and 25 (52.1%) embryos reached day 3. One blastocyst was achieved on day 5. Aberrant cleavage patterns and early embryo arrest were observed in 22 (45.8%) and 44 (91.7%) zygotes, respectively. Compared with vitrified-warmed donor oocytes, a delay was observed in pronuclei disappearance, t2 (time to reach 2 cell stage) timings, and CC1 (the duration of the 1st cell cycle) and SS3 (synchronization of cleavage pattern (calculated as t8-t5) time intervals. A normal genetic pattern was seen in 42% embryos. The proportion of vitrified oocytes was negatively associated with progesterone (odds ratio, 0.76) and positively associated with antimüllerian hormone serum levels (odds ratio, 1.23). The highest vitrification rate was achieved by the morphologic characteristic 344 at day 0 and by 433 at day 2. Ovarian tissue oocytes matured in vitro show low developmental capacity in transgender men, when collected under testosterone treatment.

Identifiants

pubmed: 33832736
pii: S0015-0282(21)00214-4
doi: 10.1016/j.fertnstert.2021.03.009
pii:
doi:

Substances chimiques

Androgens 0
Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1068-1076

Informations de copyright

Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Sylvie Lierman (S)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Annelies Tolpe (A)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Ilse De Croo (I)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Stefanie De Gheselle (S)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Justine Defreyne (J)

Department of Endocrinology - Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium.

Machteld Baetens (M)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Annelies Dheedene (A)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Roos Colman (R)

Biostatistics Unit, Ghent University Hospital, Ghent, Belgium.

Björn Menten (B)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Guy T'Sjoen (G)

Department of Endocrinology - Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium.

Petra De Sutter (P)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.

Kelly Tilleman (K)

Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium. Electronic address: Kelly.Tilleman@UZGent.Be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH